AMRAX
Price
$6.98
Change
+$0.04 (+0.58%)
Updated
Oct 3 closing price
Net Assets
19.6M
RGEBX
Price
$84.79
Change
+$0.03 (+0.04%)
Updated
Oct 3 closing price
Net Assets
341.24B
Interact to see
Advertisement

AMRAX vs RGEBX

Header iconAMRAX vs RGEBX Comparison
Open Charts AMRAX vs RGEBXBanner chart's image
American Growth One A
Price$6.98
Change+$0.04 (+0.58%)
VolumeN/A
Net Assets19.6M
American Funds Growth Fund of Amer R2E
Price$84.79
Change+$0.03 (+0.04%)
VolumeN/A
Net Assets341.24B
AMRAX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
AMRAX vs. RGEBX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRAX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 341B vs. AMRAX (19.6M). AMRAX (0.00) and RGEBX (0.00) have matching dividends . AMRAX was incepted earlier than RGEBX: AMRAX (30 years) vs RGEBX (11 years). AMRAX (4.63) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. AMRAX (4.00). AMRAX has a lower initial minimum investment than RGEBX: AMRAX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 14.91 vs. AMRAX (-8.04). RGEBX return over 5 years is better than : 43.77 vs. AMRAX (4.80).
AMRAXRGEBXAMRAX / RGEBX
Total Expense Ratio4.631.09425%
Annual Report Gross Expense Ratio4.631.09425%
Fund Existence30 years11 years-
Gain YTD4.64818.68725%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets19.6M341B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-8.0414.91-54%
Returns for 3 years23.1065.2535%
Returns for 5 years4.8043.7711%
Returns for 10 years70.2498.9271%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JANX24.000.69
+2.96%
Janux Therapeutics
NVEC68.441.86
+2.79%
NVE Corp
JNJ188.642.66
+1.43%
Johnson & Johnson
SSD171.221.99
+1.18%
Simpson Manufacturing Co
OTLK1.06-0.01
-0.93%
Outlook Therapeutics